BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3780857)

  • 1. Charge but not chemical class explains the selective binding of [3H]N-methylscopolamine to a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat cerebral cortex homogenates.
    Lee NH; Ramkumar V; el-Fakahany EE
    Eur J Pharmacol; 1986 Oct; 130(1-2):153-5. PubMed ID: 3780857
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.
    Lee JH; el-Fakahany EE
    Eur J Pharmacol; 1985 Apr; 110(2):263-6. PubMed ID: 3987816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
    Gao ZG; Liu CG
    Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of muscarinic receptors on rat pancreatic acini by using 125I-quinuclidinyl benzilate and N-[3H]-methylscopolamine].
    Aoki E; Adachi H; Noguchi M; Satoh S; Ohnishi S; Honda T; Konishi J
    Nihon Shokakibyo Gakkai Zasshi; 1991 Aug; 88(8):1571-8. PubMed ID: 1942611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alkylating derivative of oxotremorine interacts irreversibly with the muscarinic receptor.
    Ehlert FJ; Jenden DJ; Ringdahl B
    Life Sci; 1984 Mar; 34(10):985-91. PubMed ID: 6700365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trihexyphenidyl--further evidence for muscarinic receptor subclassification.
    Tien XY; Wallace LJ
    Biochem Pharmacol; 1985 Feb; 34(4):588-90. PubMed ID: 3970729
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence of paired M2 muscarinic receptors.
    Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic antagonist binding to intact rat thymocytes.
    Maslinski W; Grabczewska E; Bartfai T; Ryzewski J
    Acta Chem Scand (Cph); 1990 Feb; 44(2):147-51. PubMed ID: 2206705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]N-Methylscopolamine binding to muscarinic receptors in intact adult rat brain cell aggregates.
    Lee JH; el-Fakahany EE
    Biochem Pharmacol; 1985 Dec; 34(24):4299-303. PubMed ID: 4074390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of ligand binding in homogenate and section preparations.
    Dohanich GP; Halpain S; Lambdin LT; McEwen BS
    Brain Res; 1986 Feb; 366(1-2):338-42. PubMed ID: 3697689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.
    Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
    Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
    Ehlert FJ; Delen FM
    Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.